{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:49:33Z","timestamp":1780613373029,"version":"3.54.1"},"reference-count":55,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2015,6,4]]},"DOI":"10.3233\/jnd-150078","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T05:22:47Z","timestamp":1432876967000},"page":"107-112","source":"Crossref","is-referenced-by-count":24,"title":["Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders"],"prefix":"10.1177","volume":"2","author":[{"given":"Delmont","family":"Emilien","sequence":"first","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"},{"name":"Referral centre for ALS and Neuromuscular diseases, hospital La Timone, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willison","family":"Hugh","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JND-150078_ref1","doi-asserted-by":"crossref","first-page":"XI","DOI":"10.1016\/S0079-6123(08)61935-4","article-title":"Designation and schematic structure of gangliosides and allied glycosphingolipids","volume":"101","author":"Svennerholm","year":"1994","journal-title":"Prog Brain Res"},{"issue":"16","key":"10.3233\/JND-150078_ref2","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1113\/jphysiol.2009.171702","article-title":"Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction","volume":"587","author":"Plomp","year":"2009","journal-title":"J Physiol"},{"key":"10.3233\/JND-150078_ref3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(02)00028-0","article-title":"A sensitive flow cytometry method for anti-GM1 antibodies detection","volume":"125","author":"Escande-Beillard","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"11-12","key":"10.3233\/JND-150078_ref4","first-page":"1277","article-title":"Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies","volume":"59","author":"Caudie","year":"2013","journal-title":"Clin Lab"},{"issue":"1","key":"10.3233\/JND-150078_ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.3233\/JND-150078_ref6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2014.11.001","article-title":"Improving the detection of IgM antibodies against glycolipids complexes of GM1 and Galactocerebroside in Multifocal Motor Neuropathy using glycoarray and ELISA assays","volume":"278","author":"Delmont","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10.3233\/JND-150078_ref7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.45.8.1570","article-title":"Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis","volume":"45","author":"Van Schaik","year":"1995","journal-title":"Neurology"},{"key":"10.3233\/JND-150078_ref8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cbpa.2014.01.008","article-title":"The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders","volume":"18","author":"Galban-Horcajo","year":"2014","journal-title":"Curr Opin Chem Biol"},{"issue":"10","key":"10.3233\/JND-150078_ref9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","article-title":"Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies","volume":"13","author":"Lim","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.3233\/JND-150078_ref10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and Miller Fisher syndromes\u2013new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.3233\/JND-150078_ref11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mus.24192","article-title":"Acute and chronic ataxic neuropathies with disialosyl antibodies: A continuous clinical spectrum and a common pathophysiological mechanism","volume":"49","author":"Yuki","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-150078_ref12","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"5","key":"10.3233\/JND-150078_ref13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/WCO.0b013e328364caca","article-title":"Multifocal motor neuropathy","volume":"26","author":"Guimar\u00e3es-Costa","year":"2013","journal-title":"Curr Opin Neurol"},{"issue":"22","key":"10.3233\/JND-150078_ref14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181ff94c2","article-title":"Multifocal motor neuropathy: Association of anti-GM1 IgM antibodies with clinical features","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JND-150078_ref15","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JND-150078_ref16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2009.185736","article-title":"Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: Response to IVIg therapy","volume":"81","author":"Attarian","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.3233\/JND-150078_ref17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes as new target antigens in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann Neurol"},{"issue":"12","key":"10.3233\/JND-150078_ref18","doi-asserted-by":"crossref","first-page":"e82337","DOI":"10.1371\/journal.pone.0082337","article-title":"Antibodies to heteromeric glycolipid complexes in guillain-barr\u00e9 syndrome","volume":"8","author":"Rinaldi","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/JND-150078_ref19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.0000000000000577","article-title":"Antibodies to single glycolipids and glycolipid complexes in Guillain-Barr\u00e9 syndrome subtypes","volume":"83","author":"Shahrizaila","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.3233\/JND-150078_ref20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jnnp-2013-305755","article-title":"Sensitivity and predictive value of anti-GM1\/galactocerebroside IgM antibodies in multifocal motor neuropathy","volume":"85","author":"Nobile-Orazio","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.3233\/JND-150078_ref21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.48.4.1104","article-title":"Multifocal motor neuropathy: Serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GMl alone","volume":"48","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-150078_ref22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1331.2012.03767.x","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","volume":"20","author":"Galban-Horcajo","year":"2013","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.3233\/JND-150078_ref23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.plipres.2009.09.001","article-title":"Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding","volume":"49","author":"Rinaldi","year":"2010","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.3233\/JND-150078_ref24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"issue":"31","key":"10.3233\/JND-150078_ref25","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human gangliosideGM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"10.3233\/JND-150078_ref26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(97)00130-6","article-title":"Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides","volume":"80","author":"Jacobs","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"10.3233\/JND-150078_ref27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2005.12.005","article-title":"Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barr\u00e9 syndrome","volume":"174","author":"Caporale","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.3233\/JND-150078_ref28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410390404","article-title":"Experimental sensory neuropathy induced by sensitization with ganglioside GD1b","volume":"39","author":"Kusunoki","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JND-150078_ref29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-150078_ref30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/joa.12088","article-title":"The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies","volume":"224","author":"Fewou","year":"2014","journal-title":"J Anat"},{"issue":"4","key":"10.3233\/JND-150078_ref31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410310407","article-title":"Experimental conduction block induced by serum from a patient with anti-GM1 antibodies","volume":"31","author":"Santoro","year":"1992","journal-title":"Ann Neurol"},{"issue":"10","key":"10.3233\/JND-150078_ref32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JND-150078_ref33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JND-140039","article-title":"Anti-GQ1b ganglioside positive Miller Fisher syndrome \u2013 evidence of paranodal pathology on nerve biopsy","volume":"1","author":"Miller","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"3","key":"10.3233\/JND-150078_ref34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"issue":"12","key":"10.3233\/JND-150078_ref35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neurol.2009.04.008","article-title":"Les polyneuropathies avec IgM monoclonale anti-MAG: \u00e9tude descriptive clinique, biologique, \u00e9lectrophysiologique et anatomopathologique d\u2019une cohorte de 13 patients","volume":"165","author":"Launay","year":"2009","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JND-150078_ref36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Societ","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.3233\/JND-150078_ref37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1388-2457(01)00469-2","article-title":"Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies","volume":"112","author":"Attarian","year":"2001","journal-title":"Clin Neurophysiol"},{"issue":"9","key":"10.3233\/JND-150078_ref38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0b013e3181b59a80","article-title":"Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy","volume":"73","author":"Kuijf","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JND-150078_ref39","first-page":"353","article-title":"[Diagnostic value of autoantibodies to MAG by ELISA B\u00fchlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG\/SGLPG]","volume":"64","author":"Caudie","year":"2006","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.3233\/JND-150078_ref40","first-page":"1","article-title":"Binding specificity of anti-HNK-1 IgMM-protein in anti-MAG neuropathy: Possible clinical relevance","author":"Hamada","year":"2014","journal-title":"Neurosci Res"},{"issue":"3","key":"10.3233\/JND-150078_ref41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4172\/2329-8790.1000142","article-title":"Heavy\/Light Chain Ratio as a Biomarker for Monitoring Patients with IgM Monoclonal Gammopathy and Anti-MAG Neuropathy","volume":"2","author":"Planche","year":"2014","journal-title":"J Hematol Thrombo Dis"},{"key":"10.3233\/JND-150078_ref42","first-page":"CD002827","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","volume":"5","author":"Lunn","year":"2012","journal-title":"Cochrane database Syst Rev"},{"key":"10.3233\/JND-150078_ref43","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"L\u00e9ger","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JND-150078_ref44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy","volume":"65","author":"Dalakas","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JND-150078_ref45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1529-8027.2007.00129.x","article-title":"Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M","volume":"12","author":"Benedetti","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.3233\/JND-150078_ref46","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12658"},{"issue":"1","key":"10.3233\/JND-150078_ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(96)00042-2","article-title":"Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"70","author":"Yuki","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"10.3233\/JND-150078_ref48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jneuroim.2014.09.001","article-title":"Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy","volume":"276","author":"Notturno","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.3233\/JND-150078_ref49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"issue":"23","key":"10.3233\/JND-150078_ref50","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-150078_ref51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp-2012-303440","article-title":"Clinical features of CIDP with LM1-associated antibodies","volume":"84","author":"Kuwahara","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.3233\/JND-150078_ref52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-150078_ref53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barr\u00e9 syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-150078_ref54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0000000000000581","article-title":"Ranvier revisited: Novel nodal antigens stimulate interest in GBS pathogenesis","volume":"83","author":"Willison","year":"2014","journal-title":"Neurology"},{"issue":"15","key":"10.3233\/JND-150078_ref55","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1523\/JNEUROSCI.4662-13.2014","article-title":"Differential stability of PNS and CNS nodal complexes when neuronal neurofascin is lost","volume":"34","author":"Desmazieres","year":"2014","journal-title":"J Neurosci"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-150078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:55Z","timestamp":1777506775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-150078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":55,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jnd-150078","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}